Improvement in left ventricular systolic and diastolic performance during ranolazine treatment in patients with stable angina

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 16, Issue 2, 2011, Pages 168-172

  Figueredo, Vincent M ^a   Pressman, Gregg S ^a   Romero Corral, Abel ^b,c   Murdock, Elmer ^a   Holderbach, Pat ^a   Morris, D Lynn ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

African American; Angina; Diastolic dysfunction; Echocardiography; Ranolazine; Systolic function

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NITRATE; RANOLAZINE;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE INCREASE; DRUG MECHANISM; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HUMAN; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; SYSTOLE;

ACETANILIDES; ADMINISTRATION, ORAL; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ECHOCARDIOGRAPHY, DOPPLER; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79960175880     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248410382105     Document Type: Article

References (24)

1. Undrovinas Al, Belardinelli L, Undrovinas NA, Sabbah HN. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol. 2006;17(suppl 1): S169-S177.
2. Belardinelli L, Antzelevitch C, Fraser H. Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function. Eur Heart J. 2004; 6(suppl 1): 13-17.
3. Maier LS. A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine. J Cardiovasc Pharmacol. 2009;54(4):279-286.
4. Stone PH. Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias. Cardiol Clin. 2008;26(4):603-614.
5. Belardinelli L, Shyrock J, Fraser H. The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction. Eur Heart J. 2006;8:A10-A13. (Pubitemid 43170517)
6. Wu Y, Song Y, Belardinelli L, Shryock JC. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoylL-carnitine to increase late INa and cause ventricular diastolic dysfunction. J Pharmacol Exp Ther. 2009;330(2):550-557.
7. Antzelevitch C, Belardinelli L, Zygmunt AC, et al. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation. 2004;110(8): 904-910. (Pubitemid 39136212)
8. Song Y, Shryock JC, Wu L, Belardinelli L. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes. J Cardiovasc Pharmacol. 2004; 44(2):192-199. (Pubitemid 38982162)
9. Hale SL, Shryock JC, Belardinelli L, Sweeney M, Kloner RA. Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol. 2008;44(6):954-967.
10. Hwang H, Arcidi JM Jr, Hale SL, et al. Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts. Circulation. 2009; 120(11 suppl):S16-S21.
11. Matsumura H, Hara A, Hashizume H, Maruyama K, Abiko Y. Protective effects of ranolazine, a novel anti-ischemic drug, on the hydrogen peroxide-induced derangements in isolated, perfused rat heart: comparison with dichloroacetate. Jpn J Pharmacol. 1998; 77(1):31-39. (Pubitemid 28263988)
12. Zhang XQ, Yamada S, Barry WH. Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia. J Cardiovasc Pharmacol. 2008;51(5):443-449.
13. Hwang H, Arcidi JM Jr, Hale SL, et al. Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application. J Cardiovasc Pharmacol Ther. 2009;14(2):125-133.
14. Sossalla S, Wagner S, Rasenack EC, et al. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts-role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol. 2008;45(1):32-43.
15. Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol. 2008;19(12):1289-1293.
16. Hayashida W, van Eyll C, Rousseau MF, Pouleur H. Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease. Cardiovasc Drugs Ther. 1994;8(5):741-747. (Pubitemid 24376754)
17. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26(6):357-366. (Pubitemid 26011184)
18. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997;10(2):169-178. (Pubitemid 127789844)
19. Su HM, Lin TH, Voon WC, et al. Correlation of Tei index obtained from tissue Doppler echocardiography with invasive measurements of left ventricular performance. Echocardiography. 2007;24(3):252-257.
20. Gaibazzi N, Petrucci N, Ziacchi V. Left ventricle myocardial performance index derived either by conventional method or mitral annulus tissue-Doppler: a comparison study in healthy subjects and subjects with heart failure. J Am Soc Echocardiogr. 2005;18(12):1270-1276. (Pubitemid 41821170)
21. Cannesson M, Jacques D, Pinsky MR, Gorcsan J 3rd. Effects of modulation of left ventricular contractile state and loading conditions on tissue Doppler myocardial performance index. Am J Physiol Heart Circ Physiol. 2006;290(5): H1952-H1959.
22. Gillebert TC, Van de Veire N, De Buyzere ML, De Sutter J. Time intervals and global cardiac function. Use and limitations. Eur Heart J. 2004;25(24):2185-2186. (Pubitemid 39592418)
23. Oh JK, Tajik J. The return of cardiac time intervals: the phoenix is rising. J Am Coll Cardiol. 2003;42(8):1471-1474. (Pubitemid 37267292)
24. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol. 2007;49(19): 1903-1914. (Pubitemid 46711162)